polyvalent pneumococcal vaccine ( merck ) has recently been licensed and has been suggested for use in patients with hodgkin disease who are at risk for postsplenectomy sepsis .
C0305065
polyvalent pneumococcal vaccine
C0019829
hodgkin disease